Deutsche Bank set a €70.00 ($81.40) price objective on Compugroup Medical (ETR:COP) in a research report sent to investors on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
COP has been the subject of a number of other reports. Hauck & Aufhaeuser set a €40.00 ($46.51) target price on Compugroup Medical and gave the stock a sell rating in a research note on Tuesday, February 5th. Baader Bank set a €49.00 ($56.98) target price on Compugroup Medical and gave the stock a buy rating in a research note on Monday, February 4th. HSBC set a €60.00 ($69.77) target price on Compugroup Medical and gave the stock a buy rating in a research note on Tuesday, March 19th. Warburg Research set a €53.50 ($62.21) target price on Compugroup Medical and gave the stock a buy rating in a research note on Monday, February 4th. Finally, Berenberg Bank set a €57.00 ($66.28) target price on Compugroup Medical and gave the stock a neutral rating in a research note on Monday, April 8th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of €57.00 ($66.28).
Shares of COP opened at €62.35 ($72.50) on Wednesday. Compugroup Medical has a 52-week low of €37.64 ($43.77) and a 52-week high of €60.90 ($70.81). The firm has a market capitalization of $3.09 billion and a price-to-earnings ratio of 31.49. The company has a debt-to-equity ratio of 126.17, a current ratio of 0.95 and a quick ratio of 0.76.
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.
Further Reading: Mutual Funds
Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.